Suppr超能文献

从动态组合化学到可逆和不可逆髓过氧化物酶抑制剂的评估

From Dynamic Combinatorial Chemistry to Evaluation of Reversible and Irreversible Myeloperoxidase Inhibitors.

作者信息

Soubhye Jalal, Gelbcke Michel, Van Antwerpen Pierre, Dufrasne François, Boufadi Mokhtaria Yasmina, Nève Jean, Furtmüller Paul G, Obinger Christian, Zouaoui Boudjeltia Karim, Meyer Franck

机构信息

Chimie Pharmaceutique Organique, Faculty of pharmacy, Université Libre de Bruxelles (ULB) , Boulevard du Triomphe, 1050 Bruxelles, Belgium.

Chimie Pharmaceutique Organique, Faculty of pharmacy, Université Libre de Bruxelles (ULB), Boulevard du Triomphe, 1050 Bruxelles, Belgium; Laboratory of Beneficial Microorganisms, Functional Food and Health (LMBAFS), Faculty of Natural Sciences and Life, Université de Abdelhamid Ibn Badis, 27000 Mostaganem, Algeria.

出版信息

ACS Med Chem Lett. 2016 Dec 2;8(2):206-210. doi: 10.1021/acsmedchemlett.6b00417. eCollection 2017 Feb 9.

Abstract

The implementation of dynamic combinatorial libraries allowed the determination of highly active reversible and irreversible inhibitors of myeloperoxidase (MPO) at the nanomolar level. Docking experiments highlighted the interaction between the most active ligands and MPO, and further kinetic studies defined the mode of inhibition of these compounds. Finally, evaluation showed that one dose of irreversible inhibitors is able to suppress the activity of MPO after inducing inflammation.

摘要

动态组合库的应用使得能够在纳摩尔水平上确定髓过氧化物酶(MPO)的高活性可逆和不可逆抑制剂。对接实验突出了最具活性的配体与MPO之间的相互作用,进一步的动力学研究确定了这些化合物的抑制模式。最后,评估表明一剂不可逆抑制剂能够在诱发炎症后抑制MPO的活性。

相似文献

2
Characterization of chemical features of potent myeloperoxidase inhibitors.强效髓过氧化物酶抑制剂的化学特征表征
Future Med Chem. 2016 Jul;8(11):1163-77. doi: 10.4155/fmc-2016-0031. Epub 2016 Jul 12.
4
MPO Inhibitors Selected by Virtual Screening.基于虚拟筛选的髓过氧化物酶抑制剂
Mol Inform. 2011 Jun;30(6-7):605-13. doi: 10.1002/minf.201100016. Epub 2011 Jun 28.

引用本文的文献

6
Inhibition of Myeloperoxidase.抑制髓过氧化物酶。
Handb Exp Pharmacol. 2021;264:261-285. doi: 10.1007/164_2020_388.

本文引用的文献

1
MPO Inhibitors Selected by Virtual Screening.基于虚拟筛选的髓过氧化物酶抑制剂
Mol Inform. 2011 Jun;30(6-7):605-13. doi: 10.1002/minf.201100016. Epub 2011 Jun 28.
2
Characterization of chemical features of potent myeloperoxidase inhibitors.强效髓过氧化物酶抑制剂的化学特征表征
Future Med Chem. 2016 Jul;8(11):1163-77. doi: 10.4155/fmc-2016-0031. Epub 2016 Jul 12.
3
Myeloperoxidase Inhibitors as Potential Drugs.髓过氧化物酶抑制剂作为潜在药物
Curr Drug Metab. 2015;16(3):168-90. doi: 10.2174/138920021603150812120640.
6
Neutrophil interactions with the vascular endothelium.中性粒细胞与血管内皮的相互作用。
Int Immunopharmacol. 2013 Dec;17(4):1167-75. doi: 10.1016/j.intimp.2013.05.034. Epub 2013 Jul 14.
10
Myeloperoxidase: a target for new drug development?髓过氧化物酶:新药研发的靶点?
Br J Pharmacol. 2007 Nov;152(6):838-54. doi: 10.1038/sj.bjp.0707358. Epub 2007 Jun 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验